{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:02:12Z","timestamp":1784761332269,"version":"3.55.0"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The long-term outcomes of solid organ transplantation remain suboptimal. Therefore, appropriate biomarkers are needed in addition to immunosuppressive drugs and other traditional approaches for graft monitoring to achieve personalized immunosuppression and reduce premature graft loss.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Donor-derived cell-free DNA (dd-cfDNA) is a minimally invasive biomarker of cell death due to graft injury. It can be quantified using droplet digital polymerase chain reaction and next-generation sequencing. Fractional dd-cfDNA determination can be affected by changes in recipient cfDNA, such as those caused by leukopenia or infection, leading to false-positive or false-negative results, respectively. Absolute quantification of dd-cfDNA helps in overcoming this limitation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Overall, there is sufficient evidence of the clinical validity of dd-cfDNA. It detects rejection episodes early at an actionable stage and reflects the severity of graft injury without being rejection-specific. Owing to its high negative predictive value, dd-cfDNA is very useful for ruling out graft injury. Dd-cfDNA complements histological findings and can help in avoiding unnecessary biopsies. It indicates a response to rejection treatment and detects underimmunosuppression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Monitoring changes in dd-cfDNA over time may be helpful in adapting immunosuppression to prevent graft rejection. Moreover, serial dd-cfDNA determination may increase the effectiveness of transplant recipient surveillance and facilitate personalized immunosuppression when combined with other relevant clinical and diagnostic findings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ftd.0000000000001023","type":"journal-article","created":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T00:00:38Z","timestamp":1663718438000},"page":"20-25","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":21,"title":["Donor-Derived Cell-free DNA for Personalized Immunosuppression in Renal Transplantation"],"prefix":"10.1097","volume":"45","author":[{"given":"Michael","family":"Oellerich","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacology, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klemens","family":"Budde","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Intensive Care, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin, and Berlin Institute of Health, Berlin, Germany; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilgin","family":"Osmanodja","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Intensive Care, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin, and Berlin Institute of Health, Berlin, Germany; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Bornemann-Kolatzki","sequence":"additional","affiliation":[{"name":"Chronix Biomedical GmbH, G\u00f6ttingen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Beck","sequence":"additional","affiliation":[{"name":"Chronix Biomedical GmbH, G\u00f6ttingen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekkehard","family":"Sch\u00fctz","sequence":"additional","affiliation":[{"name":"Chronix Biomedical GmbH, G\u00f6ttingen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip D.","family":"Walson","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260519","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.clinbiochem.2017.01.007","article-title":"Therapeutic drug monitoring \u2013 key to personalized pharmacotherapy","volume":"50","author":"Oellerich","year":"2017","journal-title":"Clin Biochem."},{"key":"R2-20260519","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/FTD.0000000000000871","article-title":"Personalized therapy for mycophenolate: consensus report by the international association of therapeutic drug monitoring and clinical toxicology","volume":"43","author":"Bergan","year":"2021","journal-title":"Ther Drug Monit."},{"key":"R3-20260519","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/FTD.0000000000000260","article-title":"Therapeutic drug monitoring of everolimus: a consensus report","volume":"38","author":"Shipkova","year":"2016","journal-title":"Ther Drug Monit."},{"key":"R4-20260519","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/FTD.0000000000000640","article-title":"Therapeutic drug monitoring of tacrolimus-personalized therapy: second consensus report","volume":"41","author":"Brunet","year":"2019","journal-title":"Ther Drug Monit."},{"key":"R5-20260519","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/ajt.16502","article-title":"OPTN\/SRTR 2019 annual data report: Kidney","volume":"21","author":"Hart","year":"2021","journal-title":"Am J Transpl."},{"key":"R6-20260519","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1432-2277.2011.01320.x","article-title":"Accumulation of elderly ESRD patients with blood group O on the waiting list","volume":"24","author":"Liefeldt","year":"2011","journal-title":"Transpl Int."},{"key":"R7-20260519","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1681\/ASN.2020081215","article-title":"Exploring the complexity of death-censored kidney allograft failure","volume":"32","author":"Mayrdorfer","year":"2021","journal-title":"J Am Soc Nephrol."},{"key":"R8-20260519","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/FTD.0000000000000287","article-title":"Barcelona consensus on biomarker-based immunosuppressive drugs management in solid organ transplantation","volume":"38","author":"Brunet","year":"2016","journal-title":"Ther Drug Monit."},{"key":"R9-20260519","first-page":"3","article-title":"An economic analysis of the cost effectiveness of blood gene expression profiling in kidney transplant recipients","volume":"3","author":"First","year":"2017","journal-title":"J Health Med Econom."},{"key":"R10-20260519","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41581-021-00428-0","article-title":"Liquid biopsies: donor-derived cell-free DNA for the detection of kidney allograft injury","volume":"17","author":"Oellerich","year":"2021","journal-title":"Nat Rev Nephrol."},{"key":"R11-20260519","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1681\/ASN.2005030285","article-title":"American society of nephrology renal research report","volume":"16","author":"American Society of Nephrology","year":"2005","journal-title":"J Am Soc Nephrol."},{"key":"R12-20260519","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1111\/ajt.15416","article-title":"Absolute quantification of donor-derived cell-free DNA as a marker of rejection and graft injury in kidney transplantation: results from a prospective observational study","volume":"19","author":"Oellerich","year":"2019","journal-title":"Am J Transpl."},{"key":"R13-20260519","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/TP.0000000000002482","article-title":"Donor-specific cell-free DNA as a biomarker in solid organ transplantation: a systematic review","volume":"103","author":"Knight","year":"2019","journal-title":"Transplantation"},{"key":"R14-20260519","doi-asserted-by":"crossref","first-page":"241ra77","DOI":"10.1126\/scitranslmed.3007803","article-title":"Circulating cell-free DNA enables noninvasive diagnosis of heart transplant rejection","volume":"6","author":"De Vlaminck","year":"2014","journal-title":"Sci Transl Med."},{"key":"R15-20260519","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(05)79055-3","article-title":"Presence of donor-specific DNA in plasma of kidney and liver-transplant recipients","volume":"351","author":"Lo","year":"1998","journal-title":"Lancet"},{"key":"R16-20260519","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/ajt.15142","article-title":"Diagnostic application of kidney allograft-derived absolute cell-free DNA levels during transplant dysfunction","volume":"19","author":"Whitlam","year":"2019","journal-title":"Am J Transpl."},{"key":"R17-20260519","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1097\/TP.0000000000003240","article-title":"Adding insult on injury: immunogenic role for donor-derived cell-free DNA?","volume":"104","author":"Dholakia","year":"2020","journal-title":"Transplantation"},{"key":"R18-20260519","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jim.2018.09.011","article-title":"Characteristics, properties, and potential applications of circulating cell-free DNA in clinical diagnostics: a focus on transplantation","volume":"463","author":"Sherwood","year":"2018","journal-title":"J Immunol Methods"},{"key":"R19-20260519","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1073\/pnas.1508736112","article-title":"Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments","volume":"112","author":"Sun","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"R20-20260519","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/TP.0b013e318295ee5a","article-title":"A rapid noninvasive assay for the detection of renal transplant injury","volume":"96","author":"Sigdel","year":"2013","journal-title":"Transplantation"},{"key":"R21-20260519","doi-asserted-by":"crossref","first-page":"1005629","DOI":"10.1371\/journal.pcbi.1005629","article-title":"Quantification of transplant-derived circulating cell-free DNA in absence of a donor genotype","volume":"13","author":"Sharon","year":"2017","journal-title":"Plos Comput Biol."},{"key":"R22-20260519","doi-asserted-by":"crossref","first-page":"6229","DOI":"10.1073\/pnas.1013924108","article-title":"Universal noninvasive detection of solid organ transplant rejection","volume":"108","author":"Snyder","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"R23-20260519","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1373\/clinchem.2013.210328","article-title":"Digital droplet PCR for rapid quantification of donor DNA in the circulation of transplant recipients as a potential universal biomarker of graft injury","volume":"59","author":"Beck","year":"2013","journal-title":"Clin Chem."},{"key":"R24-20260519","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.jmoldx.2016.07.003","article-title":"Validation of a clinical-grade assay to measure donor-derived cell-free DNA in solid organ transplant recipients","volume":"18","author":"Grskovic","year":"2016","journal-title":"J Mol Diagn."},{"key":"R25-20260519","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/jcm8010019","article-title":"Optimizing detection of kidney transplant injury by assessment of donor-derived cell-free DNA via massively multiplex PCR","volume":"8","author":"Sigdel","year":"2019","journal-title":"J Clin Med."},{"key":"R26-20260519","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/TP.0000000000003393","article-title":"The monitoring of donor-derived cell-free DNA in kidney transplantation","volume":"105","author":"Filippone","year":"2021","journal-title":"Transplantation"},{"key":"R27-20260519","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/tri.13554","article-title":"Quantitative PCR of INDELs to measure donor-derived cell-free DNA-a potential method to detect acute rejection in kidney transplantation: a pilot study","volume":"33","author":"Dauber","year":"2020","journal-title":"Transpl Int."},{"key":"R28-20260519","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1093\/jalm\/jfaa062","article-title":"Donor-derived cell-free DNA testing in solid organ transplantation: a value proposition","volume":"5","author":"Oellerich","year":"2020","journal-title":"J Appl Lab Med."},{"key":"R29-20260519","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1097\/TP.0000000000003651","article-title":"Donor-derived cell-free DNA in solid-organ transplant diagnostics: indications, limitations, and future directions","volume":"105","author":"Kataria","year":"2021","journal-title":"Transplantation"},{"key":"R30-20260519","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1093\/clinchem\/hvaa175","article-title":"Time-dependent apparent increase in dd-cfDNA percentage in clinically stable patients between one and five years following kidney transplantation","volume":"66","author":"Schuetz","year":"2020","journal-title":"Clin Chem."},{"key":"R31-20260519","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/TXD.0000000000001237","article-title":"Absolute or relative quantification of donor-derived cell-free DNA in kidney transplant recipients: case series","volume":"7","author":"Osmanodja","year":"2021","journal-title":"Transpl Direct"},{"key":"R32-20260519","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1111\/tri.13753","article-title":"Donor-derived cell-free DNA as a biomarker for rejection after kidney transplantation: a systematic review and meta-analysis","volume":"33","author":"Wijtvliet","year":"2020","journal-title":"Transpl Int."},{"key":"R33-20260519","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/TP.0000000000003443","article-title":"Diagnostic accuracy of donor-derived cell-free DNA in renal-allograft rejection: a meta-analysis","volume":"105","author":"Xiao","year":"2021","journal-title":"Transplantation"},{"key":"R34-20260519","doi-asserted-by":"crossref","first-page":"0208207","DOI":"10.1371\/journal.pone.0208207","article-title":"Plasma donor-derived cell-free DNA kinetics after kidney transplantation using a single tube multiplex PCR assay","volume":"13","author":"Gielis","year":"2018","journal-title":"PLoS One"},{"key":"R35-20260519","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1097\/TXD.0000000000001301","article-title":"Donor-derived cell-free DNA as a graft injury marker following kidney transplantation","volume":"8","author":"Lane","year":"2022","journal-title":"Transpl Direct"},{"key":"R36-20260519","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1681\/ASN.2016091034","article-title":"Cell-free DNA and active rejection in kidney allografts","volume":"28","author":"Bloom","year":"2017","journal-title":"J Am Soc Nephrol."},{"key":"R37-20260519","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1681\/ASN.2021091191","article-title":"The trifecta study: comparing plasma levels of donor-derived cell-free DNA with the molecular phenotype of kidney transplant biopsies","volume":"33","author":"Halloran","year":"2022","journal-title":"J Am Soc Nephrol."},{"key":"R38-20260519","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1093\/clinchem\/hvaa199","article-title":"The proportion of donor-specific cell-free DNA in blood as a marker of transplant rejection: not an absolute","volume":"66","author":"De Vlaminck","year":"2020","journal-title":"Clin Chem."},{"key":"R39-20260519","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1093\/clinchem\/hvab183","article-title":"Molecular approaches to transplant monitoring: is the horizon here?","volume":"67","author":"Agbor-Enoh","year":"2021","journal-title":"Clin Chem."},{"key":"R40-20260519","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/phar.1426","article-title":"Antibody-mediated rejection in kidney transplantation: a review of pathophysiology, diagnosis, and treatment options","volume":"34","author":"Kim","year":"2014","journal-title":"Pharmacotherapy"},{"key":"R41-20260519","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1097\/TP.0000000000002566","article-title":"Subclinical antibody-mediated rejection after kidney transplantation: treatment outcomes","volume":"103","author":"Parajuli","year":"2019","journal-title":"Transplantation"},{"key":"R42-20260519","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1111\/ajt.15289","article-title":"Early clinical experience using donor-derived cell-free DNA to detect rejection in kidney transplant recipients","volume":"19","author":"Huang","year":"2019","journal-title":"Am J Transpl."},{"key":"R43-20260519","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1136\/heartjnl-2012-302759","article-title":"Non-invasive approaches for the diagnosis of acute cardiac allograft rejection","volume":"99","author":"Miller","year":"2013","journal-title":"Heart"},{"key":"R44-20260519","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/TP.0000000000003725","article-title":"Graft-derived cell-free DNA as a noninvasive biomarker of cardiac allograft rejection: a cohort study on clinical validity and confounding factors","volume":"106","author":"Knuettgen","year":"2022","journal-title":"Transplantation"},{"key":"R45-20260519","doi-asserted-by":"crossref","first-page":"e15836","DOI":"10.1172\/jci.insight.157836","article-title":"Temporary antimetabolite treatment hold boosts SARS-CoV-2 vaccination-specific humoral and cellular immunity in kidney transplant recipients","volume":"7","author":"Schrezenmeier","year":"2022","journal-title":"JCI Insight"},{"key":"R46-20260519","doi-asserted-by":"crossref","first-page":"932249","DOI":"10.12659\/AOT.932249","article-title":"Clinical rationale for a routine testing schedule using donor-derived cell-Free DNA after kidney transplantation","volume":"26","author":"Pai","year":"2021","journal-title":"Ann Transpl."},{"key":"R47-20260519","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/ajt.16150","article-title":"Economic analysis of screening for subclinical rejection in kidney transplantation using protocol biopsies and noninvasive biomarkers","volume":"21","author":"Puttarajappa","year":"2021","journal-title":"Am J Transpl."},{"key":"R48-20260519","doi-asserted-by":"crossref","first-page":"eaba2501","DOI":"10.1126\/scitranslmed.aba2501","article-title":"A urine score for noninvasive accurate diagnosis and prediction of kidney transplant rejection","volume":"12","author":"Yang","year":"2020","journal-title":"Sci Transl Med."},{"key":"R49-20260519","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/FTD.0000000000000566","article-title":"Circulating cell-free DNA-fiagnostic and prognostic applications in personalized cancer therapy","volume":"41","author":"Oellerich","year":"2019","journal-title":"Ther Drug Monit."}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T21:00:28Z","timestamp":1779224428000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000001023","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"2022-04-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}